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Abstract 
THE ROLE OF TRANSLATION INITIATION REGULATING KINASES, LK6 AND TOR, 
ON NOCICEPTOR DEVELOPMENT AND FUNCTION IN DROSOPHILA 
MELANOGASTER 
 
Haley Alexis McGuirt 
B.S., Appalachian State University 
M.S., Appalachian State University 
 
Chairperson: Dr. Andrew Bellemer 
 
 
 The cellular and molecular mechanisms responsible for nociception have been studied 
extensively, but remain incompletely understood. Dysregulation of nociceptor plasticity 
causing long lasting changes in sensitivity is likely a primary cause of chronic pain. Chronic 
pain currently affects over 100 million adults in the United States, while the Institute of 
Medicine reports that chronic pain costs the US over $500 billion dollars annually due to 
expenses associated with healthcare treatments and lost productivity. Effective treatments for 
chronic pain are lacking due to our incomplete understanding of the complex mechanisms 
that underly the development and persistence of chronic pain. To improve current chronic 
pain therapies, it is important to characterize the signaling pathways responsible for 
nociceptor sensitivity. The goal of this study was to characterize the role of specific genes 
that encode components of signaling pathways that regulate unique aspects of nociceptor 
sensitivity. The model organism Drosophila melanogaster was used for this study due to the 
availability of a quantifiable response to noxious stimuli and the powerful tools available for 
 v 
genetic manipulation. This project focused on characterizing the involvement of two kinases, 
Lk6 and Target of Rapamycin (Tor), that are known to positively regulate the rate of 
translation initiation through interaction with eukaryotic initiation factor 4E (eIF4E), in the 
regulation of nociceptor sensitivity. Expression levels of Lk6 and Tor in the nociceptors of 
Drosophila larvae were altered using the GAL4/UAS-RNAi system. The effects of altered 
gene expression levels on baseline nociceptor sensitivity, dendritic morphology, and the 
development of injury induced hypersensitization were quantified. The results suggest 
nociceptor-specific knockdown of Lk6 played an important role in the development of 
thermal nociceptor sensitization following UV-induced tissue injury, while playing no role in 
baseline nociceptor sensitivity. Lk6 likely controls the translation of mRNAs known to be 
involved in nociceptor plasticity or signal transduction. Nociceptor-specific knockdown of 
Tor showed phenotypes that suggested the involvement of the Tor signaling pathway in 
baseline nociceptor sensitivity, and it is hypothesized that Tor would also play a role in the 
translation of mRNAs known to be involved in nociceptor plasticity. 
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 1 
Introduction 
Chronic Pain  
Chronic pain is defined as a pain that persists longer than 90 days or after an injury 
has healed. This medical issue has become a major epidemic across the globe. It is estimated 
that over 100 million Americans experience chronic pain each day, while globally, it is 
estimated that the number of those affected reaches 1.5 billion. Chronic pain is a major health 
problem worldwide, with an economic burden of up to $635 billion a year in health care cost 
and lost productivity in the United States alone. [1-3] A central theme outlined in a 2011 
Institute of Medicine report was that despite the fact that the treatment of chronic pain is 
extremely costly, outcomes continue to remain relatively poor. [2] A wide variety of 
treatments are being used to treat chronic pain including, antidepressant, local anesthetics, 
opioid analgesics, and tramadol. 40-60% of patients being treated for chronic pain report that 
the current therapies are ineffective for long term relief. [4] 
Evidence from recent studies support the notion that the use of opioids for the 
treatment of chronic pain only has short-term efficacy and should not be used as a long-term 
treatment option due to side effects including addiction. [5]  In 2016, the Centers for Disease 
Control (CDC) published guidelines on the use of opioids for the treatment of chronic pain as 
a response to the abundance of opioids being prescribed in combination with the alarming 
rise in opioid use disorders and deaths in the United States. Opioid prescriptions rose by 
7.3% during the years 2007-2012. During this five-year span, 259 million prescriptions were 
written, which equates to enough prescriptions for every adult in the United States to have 
one. [6-7] Recent studies have begun to illuminate cellular targets of nociception that could 
result in a variety of new therapies to treat chronic pain. The development of new treatments 
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that can target nociception more directly may provide safer and more effective alternatives to 
opioids. [8] 
 
Nociception 
Nociception is the nervous system’s response to harmful or potentially harmful, 
noxious, stimuli. Nociceptive pathways can be activated by intense chemical, mechanical, or 
thermal stimulation of sensory neuron cells called nociceptors. Nociceptors are neurons that 
are associated with free nerve endings that detect noxious thermal, mechanical, or chemical 
stimuli and are found in the skin and internal surfaces of the body. [9] The concentration of 
nociceptors varies, but they are found in greatest concentration on the skin. Nociceptors can 
be divided into two major classes: Aδ fibers and C fibers. Aδ fibers can be characterized as 
medium diameter myelinated afferents that mediate acute, well localized, “first” or fast pain. 
C fibers convey poorly localized “second” or slow pain and are characterized as small 
diameter unmyelinated afferents. [10] These nociceptors act as a protective feature as they 
are only activated when a stimulus has the potential to cause tissue damage. Nociceptors are 
able to be selectively activated due to the fact that they have activation thresholds, meaning 
that they require a minimum intensity of stimulation before they can trigger a signal that will 
be passed along the axon of the neuron to the spinal cord. [10] This means that they detect 
stimuli with the potential to cause tissue damage, but not innocuous stimuli. 
Sensory neurons extend into the spinal cord through the dorsal horn of the spinal 
cord. The dorsal root ganglion (DRG) houses the cell bodies of the sensory neurons. The 
DRG functions to transduce and modulate sensory information moving into the spinal cord. 
[11] Once the signal enters the spinal cord, the sensory neuron sends it through an 
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interneuron, or multiple interneurons, in the spinal cord to higher order brain regions for 
processing. [12-14] This process of nociception triggers a variety of physiological and 
behavioral responses that typically result in the subjective experience of pain coupled with 
behavioral reactions, such as the withdraw reflex. (Figure 1) Nociception is essential to an 
organism’s protection and survival. However, when the nociceptive pathway malfunctions, 
an organism’s ability to appropriately detect, react to, and recover from injury can be altered 
resulting in chronic pain. [14-15] 
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Figure 1.  Depiction of the activation of nociceptive nerve fibers. Detection of a noxious stimulus occurs at 
the peripheral terminals of primary afferent neurons and leads to generation of action potentials that 
propagate along the axon to the central terminals. Aβ fibers respond only to non-noxious stimuli, Aδ fibers 
respond to noxious mechanical stimuli and subnoxious thermal stimuli, and C fibers respond only to noxious 
mechanical, heat, and chemical stimuli. [16] 
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Nociceptor Plasticity 
Nociceptive pathways are activated in response to noxious of harmful stimuli. The 
acute sensation of pain produced by nociception serves as an adaptive and protective 
mechanism to detect, localize, and prevent further tissue damage. However, when pain 
persist in conditions of chronic pain, after a normal healing period has occurred (1-3 months), 
a maladaptive response has developed and is no longer beneficial to the organism’s 
protection or survival. In states of chronic pain, pain arises in the absence of noxious stimuli 
and maybe stimulated by normally innocuous stimuli due to a reduced threshold for the 
activation of nociceptors (allodynia). (Figure 2) Chronic pain conditions can also result in an 
exaggerated and prolonged response to noxious stimuli (primary hyperalgesia), and spread 
beyond the site of injury (secondary hyperalgesia). (Figure 3) [20] Neural plasticity, or 
changes within the structure and physiology of neurons or availability of the proteins 
required for nociception within primary afferent nociceptors can lead to these modes of long 
lasting hypersensitization. [14, 17-18] 
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Figure 2. Depiction of allodynia. In states of chronic pain, pain arises in the absence of 
noxious stimuli and maybe be stimulated by normally innocuous stimuli (allodynia) due 
to a reduced threshold for the activation of nociceptors. [19]  
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Figure 3. Depiction of primary (a) and secondary (b) hyperalgesia. Chronic pain conditions can result in an 
exaggerate and prolonged response to noxious stimuli (primary hyperalgesia), and spread beyond the site of 
injury (secondary hyperalgesia). [20] 
 8 
Neural plasticity within both the peripheral nervous system (PNS) and the central 
nervous system (CNS) is a major mechanism that leads to the development of chronic pain. 
[4] Chronic pain is believed to develop through neural plasticity and consequently changes in 
the excitability of peripheral nociceptive neurons, but the precise mechanisms controlling 
these changes have not been fully elucidated. It has been hypothesized that molecules which 
regulate translation play a major role in controlling the expression of genes necessary for the 
transition of nociceptors from standard activation states to states of hypersensitivity 
(allodynia or hyperalgesia). [17] 
Translational regulators, such as mammalian target of rapamycin (mTOR) kinase and 
mitogen activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) 
are involved in translation regulation pathways that play a role in neural plasticity and 
changes in nociceptor excitability. [21] Recent studies have shown that mTOR and its 
downstream effectors may be important in the development of chronic pain stemming from 
cancer, neuropathy, and inflammation. [22-24] The mTOR kinase is a master regulator of 
protein synthesis, and has been shown to be involved in several neural functions including 
synaptic plasticity. mTOR could, therefore, be a novel pharmacological target for the 
management of chronic pain. [25] It has also been shown that phosphorylation of the main 
mRNA translational regulator, eukaryotic initiation factor (eIF) 4E (eIF4E), is an additional 
mechanism that is critical for the regulation of the changes in nociceptor plasticity that drive 
the development of chronic pain. Targeting, MNK, the kinase responsible for the 
phosphorylation of eIF4E is an important potential therapeutic target for the treatment of 
chronic pain as well. [26] 
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Translation of Nascent Proteins Leads to Neural Plasticity 
Translational control within neurons contributes to the development of the peripheral 
and central nervous systems, is involved in axonal regeneration following injury, and allows 
for neuronal plasticity. Neuronal plasticity is defined as a neuron’s ability to adapt to 
environmental changes via intracellular and extracellular signaling pathways through many 
mechanisms, including changes in gene expression and thus protein abundance. The 
synthesis of new proteins has been observed in cases of injury, suggesting that upregulation 
of specific proteins is a critical factor for neuronal plasticity. [27] Gene expression is 
regulated at multiple levels, including the translation of mRNAs into proteins. Compared to 
transcriptional regulation, translational control of mRNA allows for more rapid changes in 
the cellular concentration of the encoded proteins and thus can be used to maintain 
homeostasis or induce more permanent changes such as strengthening or weakening of neural 
synapses. [28-29] 
Both mTOR and MNK are known to act upstream of translation initiation to 
positively regulate translation. Specifically, in the context of nociception, it is hypothesized 
that these translational regulators may act to regulate the expression of genes that encode 
proteins that are necessary for nociceptor hypersensitization. Evidence from many studies 
suggest that local translation, for example translation that occurs within the axon, 
independent of the cell body, is crucial for the establishment and maintenance of chronic pain 
states. Local translation of mRNA within an axon would be advantageous as it would allow 
for a more rapid and localized response to environment changes or insults. [17] Controlling 
the abundance of proteins necessary for nociception and the transition to states of 
hypersensitization, perhaps through the inhibition of translation regulators, could become a 
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central strategy in the development of pharmaceuticals used to replace opioids in the 
treatment of chronic pain. [28-30] 
 
The Basics of Translation 
Translation can be separated into three main steps: initiation, elongation, and 
termination.  Initiation is considered the most highly regulated, rate-limiting step and requires 
proper assembly of the eIF4F complex on the mRNA before ribosome recruitment and 
subsequent steps of initiation can proceed. Most eukaryotic mRNAs are translated in a cap-
dependent manner with the exception of those that are translated via internal ribosome entry 
sites (IRES). Cap-dependent translation begins when the eIF4F complex assembles and binds 
to the 5’ cap of the mRNA strand. The 5’ cap is a 7-methylguanosine attached to the first 
nucleotide of the 5’ untranslated region (UTR) of the mRNA. Following the assembly of the 
eIF4F complex, the ribosomal subunits will be recruited, and scanning of the 5’ UTR for the 
start codon will proceed. [22] 
 The eIF4F complex is comprised of three key eIFs: eIF4E, eIF4A, and eIF4G. eIF4E, 
the most highly regulated member of the eIF4F complex, is responsible for identifying and 
binding to the 5’ cap. eIF4G, the scaffolding protein, interacts directly with eIF4E, eIF4A, 
eIF3 and the poly-A binding protein (PABP). Interaction of eIF4G with PABP allows for 
circularization of the mRNA and shuffling of ribosomes from the termination codon to back 
to the 5’ cap. eIF4A and other helicases, such as Ded1 and DHX29, are responsible for 
unwinding the secondary structure of the 5’ UTR allowing for effective ribosomal scanning 
for the initiation codon. [22] 
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Assembly of the eIF4F complex is followed by recruitment of the 43S preinitiation 
complex (PIC) through direct binding to the 40S ribosomal subunit. The scanning process 
then proceeds in a 5’ to 3’ direction until the PIC, loaded with a met-tRNA, recognizes the 
start codon (AUG in most cases). After start codon recognition, the 60S ribosomal subunit is 
recruited, forming the 80S ribosomal subunit which marks the beginning of the elongation 
phase of translation. [22] (Figure 4) 
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Figure 4. Representation of cap-dependent translation. eIF4F complex binds to the 5’ cap via eIF4E. 
eIF4G binds to eIF4A and eIF3 recruiting the 43S PIC. eIF4A unwinds the 5’ UTR secondary structure 
while the PIC scans until it encounters the initiation codon. The 60S subunit joins and elongation 
commences. eIF4G interacts with PABP allowing for mRNA circularization. [22] 
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eIF4E Plays a Major Role in the Regulation of Translation Rates 
Evidence has shown that chronic pain states are accompanied by major changes in 
translational activity and thus the abundance of proteins involved in nociception. Major 
changes in the function and availability of key translational machinery and molecules 
required for normal nociception are seen in instances of tissue damage followed by chronic 
pain. [31] These changes have been directly linked to increases in eIF4F complex formation 
and nascent protein synthesis. eIF4E is the rate limiting factor for eIF4F assembly as it is 
found in least abundance. The importance of eIF4E regulation in the assembly of the eIF4F 
complex and translation initiation suggest that eIF4E could be a promising therapeutic target 
to inhibit aberrant pain plasticity. [30]  
Expression levels of eIF4E are the lowest among all of the eIFs that makeup the 
eIF4F complex, thus making formation of eIF4F complex and correspondingly translation 
initiation reliant upon the availability and activity of eIF4E. Some mRNAs are more sensitive 
to the accessibility of eIF4E than others. Translation rates of eIF4E-sensitive mRNAs are 
preferentially stimulated by increased eIF4E activity. Characteristics of these mRNAs 
include mRNAs that possess a complex secondary structure, a long guanosine/cytosine rich 
5’ UTRs, cis-regulatory elements, TOPS (5’ terminal oligopyrimidine tracts), or CERTS 
(cytosine enriched regulators of translation). eIF4E-sensitive mRNAs do not make up the 
mass majority of mRNAs involved in general translation, however they do include vital 
mRNAs critical for cell proliferation, growth, and immune responses. [28] eIF4E integrates 
cellular signals and is regulated by two major signaling pathways: MNK and mTOR. 
Inhibition of MNK and mTOR signaling alleviates the development of nociceptor 
hypersensitivity in a variety of pain models. Because MNK and mTOR converge on eIF4E to 
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control the rate of cap-dependent translation, it can be suggested that eIF4E might play a role 
in the sensitization of pain circuits by regulating the translation of specific mRNAs. [28-32] 
Depletion of eIF4E and associated proteins reduces cap-dependent translation. The 
reduction in translation due to loss of eIF4E can be mitigated when purified eIF4E is re-
introduced in vitro. [33]  Many mechanisms regulate the availability of eIF4E including 
amplification of the eIF4E gene, post-transcriptional modifications such a phosphorylation, 
and interactions with inhibitory proteins such as 4E-binding proteins (4E-BPs). [34] The 
physiological significance of eIF4E phosphorylation was studied using mice lacking eIF4E 
phosphorylation through a knock-in mutation of serine209 to alanine (eIF4ES209A). These 
mice displayed greatly reduced mechanical and thermal hypersensitivity as well as 
diminished hyperalgesic priming (prolonged inflammatory mediator-induced hyperalgesia) in 
response to intraplantar administration of proinflammatory mediators: IL-6, NGF, and 
carrageenan. This indicates that reduced phosphorylation of eIF4E results in decreased 
nociceptor sensitivity caused by inflammatory mediators. [31] 
A dominant mechanism that regulates the activity of eI4FE is through interaction with 
a family of translational suppressor proteins called 4E-binding proteins (4E-BPs). Binding of 
4E-BPs to eIF4E is highly regulated by their status of phosphorylation. Phosphorylation of 
specific serines and threonines on the 4E-BP molecule modulates the affinity of 4E-BP for 
eIF4E. 4E-BPs share a common eIF4E binding motif with eIF4G, the scaffolding protein, 
making it a competitive inhibitor. Binding of 4E-BPs to eIF4E prevent interaction of eIF4G 
and eIF4E, thus impairing the assembly of the eIF4F complex. Hyperphosphorylated 4E-BPs 
have a high binding affinity for eIF4E and readily suppress translation. [35-36]   
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eIF4E and mTOR 
mTOR is a 289-kDa serine/threonine protein kinase that phosphorylates 4E-BPs as 
well as other substrates when activated. mTOR controls many cellular processes including 
protein synthesis, cell growth, proliferation, mitochondrial function, and many other vital 
processes. [37] mTOR forms two separate complexes, mammalian target of rapamycin 
complex 1/2 (mTORC1/mTORC2). The two complexes share the following common 
subunits: LST8/G𝛽L (lethal with sec18 protein 8/G-protein beta like subunit), DEPTOR 
(domain containing mTOR-interacting proteins), and Tti1/Tel2 complex. [38-40] Separate 
from mTORC2, mTORC1 contains the Raptor (regulatory-associated protein of mammalian 
target of rapamycin) subunit and PRAS40 (proline rich Akt substrate of 40 kDa). [41-42]  
mSin1 (mammalian stress-activated map kinase-interacting protein 1), Rictor (rapamycin-
insensitive companion of mTOR), and Proctor (protein observed with Rictor, are all specific 
to mTORC2.  
mTORC1 is activated by many extracellular signals including the presence of growth 
factors and stress as well as intracellular signals including changes energy status and oxygen 
levels. [22] mTORC1 is of particular interest as the Raptor domain serves as an adaption site 
for downstream substrates 4E-BPs. The PI3K/Akt/mTOR signaling cascade is responsible for 
phosphorylation of 4E-BPs via mTORC1. (Figure 5) 
Phosphatidylinositol-3-kinase (PI3K) phosphorylates phosphatidylinositol-4,5-
bisphosphate (PIP2) to form phosphatidylinositol-3,4,5-trisphosphate (PIP3). [37] 
Membranous PIP3 then activates protein kinase B (Akt) by binding to the PH domain which 
docks Akt to the plasma membrane where it is phosphorylated by many kinases- including 
mTORC2. [43] Active Akt phosphorylates TSC2, causing reduced activity, destabilization, 
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and dissociation from the TSC1/2 complex. TSC1/2 complex acts as a mTORC1 inhibitor. 
When the TSC1/2 complex is inactivated due to dissociation of TSC2, mTORC1 is activated. 
[44] 
There are three known homologs of 4E-BP: 4E-BP1, 2, and 3. 4E-BP1 is the major 
isoform involved in regulation of nociception where 4E-BP2 is the dominant isoform in the 
brain. Active mTORC1 phosphorylates 4E-BPs. When hypophosphorylated, 4E-BPs 
compete with eIF4G for binding to eIF4E which represses eIF4F complex assembly and thus 
translation initiation.  However, when phosphorylated by mTORC1, 4E-BPs dissociate from 
eIF4E allowing eIF4G to bind which completes the formation of the eIF4F complex allowing 
translation to proceed. [45] When 4E-BP1 is deleted in mice and eIF4E is free to interact 
with other eIF4F components, the mice show mechanical hypersensitivity, increased 
excitatory synaptic input, and a lowered threshold for synaptic potentiation. [46] 
The mTORC1 cascade can be modulated by a multitude of internal and external cues. 
Two well studied signaling molecules that are involved in the activation of the 
mTORC1cascade are interleukin 6 (IL-6) and neurotrophic growth factor (NGF). IL-6 and 
NGF activate mTORC1 and, subsequently, promotion of 4E-BP1 phosphorylation. 
Intraplantar injection of IL-6 and NGF induced mechanical allodynia in mice. This 
phenomenon is mitigated through administration of mTORC1 inhibitor, rapamycin, as well 
as 4EGI-1. 4EGI-1 is a small molecule that is able to interrupt eIF4E/eIF4G interaction and 
thus formation of the eIF4F complex by competitively binding to eIF4E. 4EGI-1 also 
blocked hypersensitization after hyperalgesic priming with IL-6 and NGF. [24, 47, 48] 
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MNK Phosphorylation of eIF4E 
It has been established that eIF4E plays an important role in the recognition of the 7-
methylguanosine cap and formation of the eIF4F complex during cap-dependent translation 
of mRNA. eIF4E has a sole phosphorylation site at ser209 in mammals [49] and can exist in 
both phosphorylated and non-phosphorylated states. Phosphorylated eIF4E has a higher 
binding affinity to the 5’ cap of untranslated mRNA. [50] Higher binding affinity of eIF4E to 
the 5’ cap of mRNA results in increased assembly of the eIF4F complex and thus increased 
protein synthesis. [51] 
Phosphorylation of eIF4E has also been shown to play a critical role in the 
development of cancer. Studies in mice have shown that phosphorylation of eIF4E is 
required for translational upregulation of several proteins implicated in tumorigenesis. 
Increased phosphorylation of eIF4E has also been associated with increased disease 
progression in prostate cancer. [52] eIF4E phosphorylation is not vital for development and 
survival but has been shown to be a critical component in various disease states and 
upregulation of the translation of a specific subset of mRNAs. Many mRNAs, including 
those involved in nociceptor plasticity and pain signaling are affected by phosphorylation of 
eIF4E. The significance of eIF4E phosphorylation in nociception, as mention earlier, was 
determined in a study that mutated the lone phosphorylation site, serine209, to alanine 
(eIF4ES209A) to prevent the phosphorylation of eIF4E. These eIF4Es209A mutant mice showed 
reduced hypersensitivity and hyperalgesic priming. This result suggests that reducing the 
phosphorylation of eIF4E could provide an avenue in the production of pharmaceuticals 
aiming to treat cases of chronic nociceptor hypersensitization. [31] eIF4E kinases, such as 
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MNKs (MAPK interaction protein kinases) are an interesting target for the potential 
intervention of progressive diseases including chronic pain. [53, 54]  
MNK 1 and 2 are serine/threonine kinases that can be activated by two different 
MAPK signaling pathways: ERK (extracellular regulated kinase) and p38 via various 
extracellular signals (Figure 5).  MNK1/2 were originally discovered in a substrate screen for 
ERK1/2. [55] ERK1/2 are growth factor regulated kinases that interact downstream in the 
Ras/Raf/Mek/ERK phosphorylation cascade. When Raf is activated, it functions to 
phosphorylate MAPK/ERK kinases (Mek), which in turn phosphorylate ERK1/2. ERK1/2 
then are able to activate and phosphorylate MNK1/2. [56] The p38 MAPK pathway is 
activated by stress signals including osmotic shock, UV radiation, cytokines, and 
chemokines. [53] When p38 is activated via phosphorylation it is able to activate and 
phosphorylate MNK1/2. [53]  
Activated MNK1/2 acts a master translation regulator of eIF4E through direct 
phosphorylation on eIF4E’s sole phosphorylation site, ser209. [49] Phosphorylation of eIF4E 
by its specific kinase, MNK, regulates translation of the eIF4E sensitive mRNAs. As 
established above, phosphorylated eIF4E plays a more active role in the eIF4F translation 
initiation complex. Many experiments have been done on mice that further investigated the 
role of eIF4E phosphorylation through MNKs on translation and the development of chronic 
pain. Mice lacking MNK1/2, and thus eIF4E phosphorylation, showed reduced development 
of mechanical and cold hypersensitivity following nerve injury. These results were validated 
through further experimentation which showed that local inhibition of MNKs was also able 
to reduce mechanical hypersensitivity as well as hyperalgesic priming in response to NGF. 
MNKs phosphorylation of eIF4E is necessary for phenotypic changes within neurons that are 
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necessary for the development of chronic pain. This further suggests that eIF4E sensitive 
mRNAs are likely targeted by eIF4E dependent changes in translation during the 
development of nociceptor hypersensitization. [22, 54, 57] eIF4E is a key potential 
therapeutic target in inhibiting abnormal translation initiation involved in many pathologies 
including cancers and chronic pain. eIF4E is a central node in regulating the rate at which 
translation occurs and its activity can be altered through both the MNK and mTOR signaling 
cascades in variety of different model organism.  
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 Figure 5. Multiple signaling pathways converge on eIF4E regulating translation initiation. Substrates mTOR 
and MNK are activated and phosphorylated by upstream signaling cascades which allows for regulation of 
eIF4E activity within the translation initiation complex eIF4F. [22] 
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Drosophila melanogaster as a Model Organism 
To help illuminate the molecular mechanisms that underly the transition of 
nociceptors from normal nociception to states of chronic hypersensitivity, I am using the 
model organism Drosophila melanogaster. Drosophila has been used as a model organism 
for more than 100 years. [58]. The use of Drosophila is ideal as it combines genetic, 
behavioral, and even economic advantages. Drosophila was one of the first organisms to 
have a fully sequenced genome that consist of approximately 13,600 protein-coding genes 
that are located on only four chromosomes. [59] It has been discovered that 75% of the 
coding genes are homologous to human disease-related genes. [60] Drosophila larvae are 
cheap to maintain when compared to other model organism and are very useful in biomedical 
research as they develop very quickly and have an average lifespan of ~120 day. The 
characteristic short lifespan allows for the effective study of gene expression on development 
nociception as the development from embryo to larvae can occur in as little as 4 days. [61] 
Drosophila is also useful in biomedical research due to the variety of well-established 
molecular genetics tools that have been established over its long history as an animal model. 
Advances in manipulation of the Drosophila genome allow for tissue-specific knockdown 
and fluorescent protein expression in specific cells without altering the surrounding tissue 
environment. [62]  
 Many researchers utilize Drosophila during the larval stage of development. The life 
cycle of Drosophila goes to completion within 10 days and consists of the following phases: 
embryo, larva, pupae, adult. [63] The larval phase can further be broken down into first, 
seconds, and third instar larval stages. The third instar and most mature larval stage is used 
for experiments as it has highly characterized behavior and is amenable to microscopy. 
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Under normal conditions third instar larvae will move forward in a peristaltic motion. 
However, upon sensing a threat, or noxious stimuli, the larvae with exhibit nocifensive 
escape locomotion (NEL), which consist of a 360º barrel role along the longitudinal axis 
toward or away from a noxious stimulus. NEL behavior is an evolutionarily conserved 
mechanism that protect larva from predation, most commonly, predation from parasitoid 
wasps. This NEL behavior is quantifiable, which allows larval sensitivity to noxious stimuli 
to be measured. [15] It is also ideal that third instar larvae have a transparent epidermis that 
allows for easy imaging and analysis of florescent expressing cells, such as green fluorescent 
protein (GFP) expressing neurons, within the epidermis to study their fully developed 
nervous system. [64] 
The overarching pathways that underly the transmission of signals from nociceptors 
is conserved from Drosophila to humans. In both humans and flies, action potentials from the 
PNS are triggered by noxious stimuli and transmitted from activated nociceptors, through the 
axon, and to the CNS. Upon reaching the CNS, nociceptors synapse with secondary neurons 
and transmit the signal to higher-order processing centers. [65]  
The Drosophila sensory nervous system receives and transduces information from the 
outside environment to the CNS in order to promote appropriate larval and adult behavior. 
Somatosensory system inputs are diverse, and can be reflected by the many different 
morphologies of individual sensory organs. Sensory organs can be categorized most loosely 
in dorsal(d), lateral(l), ventral(v), and ventral’(v’) clusters. The clusters consist of neurons 
that are classified as either type I, sensilla, or type II, multidendritic (md) neurons.  Type I 
neurons include the mechanosensory external sensory organs. Type II, md neurons spread 
complex, highly branched dendritic processes and are characterized by free nerve endings 
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and that innervate external surfaces, such as the epidermis, and some internal surfaces. [66] 
Md neurons can further be classified by neurons that give rise to elaborate dendritic 
arborizations (da neurons), neurons that have bipolar dendrites (bd neurons), and neurons that 
arborize around particular tracheal branches (td neurons). The arrangement of the segmented 
peripheral neurons is highly invariant and provides a favorable system for the genetic 
analysis of neurodevelopment. [67] 
Among the mdda (multidendritic-dendritic arborization) neurons, which extend 
dendrites across the epidermis, there is considerable morphological diversity. Four distinct 
morphological classes of mdda neurons have been distinguished in Drosophila larva, 
primarily by their physiological function and patterns of dendritic complexity. The four 
classes are labeled as class I, II, III and IV neurons. A higher class-number is indicative of 
increasing arbor complexity. Class I and class II neurons have simple branching patterns, 
class III show numerous short actin-based protrusions extending from major branches, and 
class IV neurons innervate the entire epidermis with complex, space filling arbors. [68] 
(Figure 6) Molecular and functional properties correlate with these morphological 
distinctions. Class I neurons function as proprioceptors responding to stimuli from within the 
body, coordinating body position and movement. [69-70] Class II and III neurons function as 
touch receptors that respond to gentle touch. [71] Class IV neurons function as polymodal 
nociceptive (noxious sensing) neurons.[72] 
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Figure 6. Classes of multidendritic dendritic arborization neurons in Drosophila. Class I and class II 
neurons have simple branching patterns, class III show numerous short actin-based protrusions extending 
from major branches, and class IV neurons innervate the entire epidermis with complex, space filling 
arbors. [68]  
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Ion Channels Allow for Signal Transduction in Drosophila 
Dendrites of Mdda class IV neurons are the primary site for noxious sensory input in 
Drosophila. These dendrites transduce sensory input through a nociceptive pathway similar 
to the one in vertebrates described previously. (Figure 1). For most secondary neurons that 
receive afferent information, proper function of the pathways generating and propagating 
action potential within dendrites is essential. [63] 
Transient receptor potential ion channels (TRP channels), such as TRPA1, are 
expressed by nociceptive neurons are involved in peripheral sensitization and the 
development of chronic pain. [73] TRP channels were originally discovered and identified as 
important factors in sensory transduction in studies using Drosophila melanogaster. TRP 
channels are a family of ion channels that act as sensors of the environment and integrate 
signaling, and their expression in neurons determines the activation of nociceptors by 
different noxious stimuli. This group of channels utilize an ion flux as a result of activation 
by noxious stimuli. This causes neuronal membrane depolarization, which activates action 
potentials. [74-75] 
Specific to Drosophila, activation of TRPA channels in class IV mdda neurons results 
in the larval NEL response. [76] In order to understand more about the role of the nociceptive 
TRPA channels, many studies focused on the function of TRPA1. To better understand the 
role of TRPA1 in Drosophila nociception, an RNAi knockdown of TrpA1 was conducted. It 
was found that the knockdown larvae exhibited impaired avoidance of noxious heat, showing 
it is required for thermal nociception. [74] TRPA1 has also been studied in mice in which it 
was found that TRPV1 functions in the transmission of thermal nociceptive signal in 
response to noxious heat in the range of 42oC-48oC. The TRPA1 channel is essential for 
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proper thermal nociception and is a characteristic that is conserved from to Drosophila to 
animal models. [15, 76, 77].  
Responsible for the generation and conduction of electrical signals in neurons, 
voltage-gated sodium (Nav channels) are essential for neural signaling. When Nav channels 
are pharmacologically blocked, all receptor and ion channel-induced currents are halted at 
the axon and further prevented from signaling to the secondary neuron [78]. In Drosophila 
neurons, the sodium voltage-gated ion channel, paralytic (para), is required for nociceptor 
activity. When para is depleted, nociceptors cannot fire action potentials and the NEL 
response to noxious stimuli is completely lost [79-80]. Knockdown of Para in nociceptors is 
often used a positive control for reduced sensitivity of nociceptors in studies using 
Drosophila.  
Tools for studying the complexity of nociception in Drosophila have advanced in 
recent years in hopes to establish further clarity in conserved processes of nociception. A 
model of UV-induced hypersensitization has been developed in Drosophila larvae that has 
proven useful in research. This UV-induced sensitization model can be used to assess 
whether the cellular and molecular mechanisms underlying nociceptive sensitization differ 
from those that underlie baseline nociception. In this model, Drosophila larvae are exposed 
to UV radiation which causes epidermal tissue-damage resulting in increased sensitivity of 
nociceptors. UV-induced sensitization has also been effective in establishing the role of gene 
expression on various aspects of hypersensitization such as allodynia and hyperalgesia. A 
recent study was able to show that reduced function of the Drosophila homolog of TNF-𝛼, 
an evolutionarily conserved molecule that is released from damaged epidermal cells whose 
receptor is found within nociceptors, was able to mitigate the development of thermal 
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allodynia while having no effect on thermal hyperalgesia following UV-sensitization. This 
model can further be used to classify the role of other genes, such as Lk6 and Tor, on 
nociception in Drosophila.  
With a highly characterized nervous system, class IV mdda neurons as nociceptors 
that transmit sensory information through various ion channels, well-developed tools of 
genetic manipulation, and established methods for testing changes in nociception, Drosophila 
becomes an ideal organism for the study of nociceptive plasticity through translational 
control. This research utilized the insertion of a transgene in combination with a tissue 
specific driver to cell-specifically knockdown two genes of interest. The genes of interest are 
Lk6 and Tor, the Drosophila homologs of previously- mentioned kinases, mTOR and MNK, 
respectively. With this information, is was possible to study how changes in translation 
regulation and development though Lk6 and Tor loss of function effected nociception.  
[81-82] 
 
Specific Aims: 
I. Define baseline thermal and mechanical larval sensitivity when target genes, Lk6 
or Tor is knocked down. 
II. Quantify the effects of Lk6 and Tor knockdown on nociceptor morphology. 
III. Characterize the effect of Lk6 knockdown on sensitization. 
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Materials and Methods 
Drosophila Genetics 
The goal of the project was to examine the role of specific kinases in class IV mdda 
nociceptors in development and function. In order to examine the role of the kinases, RNA 
interference (RNAi) knockdown lines for each gene were crossed with flies containing tissue 
specific drivers to knockdown (KD) the expression of the genes specifically in class IV mdda 
neurons.  
RNAi is a gene silencing method that works through degradation of homologous 
messenger RNAs (mRNA). RNAi is an endogenous cellular mechanism triggered by double 
stranded RNA (dsRNA), which leads to the degradation of homologous RNAs. [83] dsRNA 
is produced through transcription of an inverted repeat or “hairpin” sequence. Upon 
introduction of dsRNA, the formation of a complex, consisting of Dicer-2 and R2D2, cuts the 
duplex RNAs into short fragments are 19-21 nucleotides. [84] This in turn induces the 
association of the argonaute protein, Ago2, which is stabilized by a HSC70/Hsp90 chaperone 
system, and then leads to the unwinding of the duplex, its cleavage, and finally ejection of 
the passenger strand [85] Subsequently, the full RNA-induced silencer complex (RISC) is 
formed. This complex identifies sequence-homologous endogenous RNAs through a 
homology-seeking activity, leading to their cleavage and degradation. 
Cell-specific RNAi was used to knock down transcript levels in the nociceptor by 
utilizing the binary GAL4/upstream activation sequence (UAS) system. The GAL4/UAS 
system is a genetic tool used to control cell-specific gene expression levels in Drosophila. To 
generate transgenic lines expressing GAL4 in various cell and tissue-specific patterns, the 
GAL4 gene is inserted randomly into the genome, driving GAL4 expression from various 
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different genomic enhancers. A GAL4-dependent target gene, in this case a UAS-RNAi 
transgene, can then be constructed by subcloning any sequence behind a GAL4 binding site. 
The target gene is silent in the absence of GAL4. To activate the target gene in the cell or 
tissue specific pattern, flies carrying the target (UAS-Gene X) are crossed to flies expressing 
GAL4 in the tissue of interest. In the progeny of this cross, it is possible to activate UAS-
Gene X in cells where GAL4 is expressed and to observe the effect of this directed 
misexpression in the case of RNAi knockdown, or on development. [2]  
The GAL4 driver used in this experiment is the pickpocket1.9-GAL4 (ppk-GAL4) 
driver which targets expression to class IV mdda neurons. Pickpocket1 (PPK1) is a 
Drosophila subunit of the epithelial sodium channel (ENaC) family displaying limited 
expression in mdda neurons. [87] The advantage of cell or tissue specific gene knockdown is 
that the cell is not completely deprived of the targeted protein; the system allows for 
expression in non-targeted cells and an increased chance of cell viability. To decrease gene 
expression in nociceptors, ppk1.9-GAL4;UAS-dicer-2 flies were crossed to UAS- RNAi lines 
for each gene of interest. (Figure 7) The RNAi degrades mRNA transcripts to result in 
reduced levels of the target protein while the presence of dicer-2 increases RNAi transcript 
activity. However, the efficiency of cell or tissue specific gene knockdown was not 
confirmed in this project, so the possibility of false positive or negative phenotypes due to 
off-target effects or leaky expression was present. [88] 
The presented research used crosses that consisted of ppk-GAL4;UAS-dicer-2 driver 
combined with UAS-RNAi to knockdown the genes of interest. The driver stocks w; ppk1.9-
GAL4; UAS-dicer2, w; ppk1.9-GAL4, UAS-mCD8::GFP; UAS-dicer2, and the w1118 control 
were obtained as gifts from the laboratory of the Dr. Dan Tracey. All other RNAi lines were 
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developed as part of the Drosophila Transgenic RNAi Project (TRiP) and obtained from the 
Bloomington Drosophila Stock Center (BDSC). (Table 1) 
Two negative controls were used to monitor the fidelity of the GAL4/UAS system, 
controlling for each portion of the binary system. The first negative control controlled for the 
GAL4 insertions. Virgin females from the GAL4 (w; ppk1.9-GAL4; UAS-dicer2) driver line 
were crossed with males from the control (y1 v1; P{y[+t7.7]=CaryP}attP2 (BDSC# 36303)) 
line. The second negative control controlled for the insertion of the following UAS-RNAi 
transgenes: Tor-RNAi, y1 sc* v1 sev21 P{y+t7.7 v+t1.8=TRiP.HMS00904}attP2 (BDSC# 33951); 
Tor-RNAi, y1 sc* v1 sev21 P{y+t7.7 v+t1.8= TRiP.GL00156}attP2 (BDSC# 35578); Tor-RNAi, 
y1 sc* v1 sev21 P{y+t7.7 v+t1.8= TRiP.HMS01114}attP2 (BDSC# 34639); Lk6-RNAi, y1 sc* v1 
sev21 P{y+t7.7 v+t1.8= TRiP.GL00264}attP2 (BDSC# 35352); Lk6-RNAi, y1 sc* v1 sev21 P{y+t7.7 
v+t1.8= TRiP.JF02993}attP2/TM3, Sb1 (BDSC# 28357). Virgin females from the control line 
(w1118) were crossed with males from the previous listed RNAi lines.  
A single positive control was generated by crossing Virgin females from the GAL4 
(w; ppk1.9-GAL4; UAS-dicer2) driver line with males from the para-RNAi line. Para 
knockdown larvae were used as a positive control and found to show nearly complete 
insensitivity to noxious thermal stimuli. Paralytic (para), is a Drosophila ion channel gene 
that encodes for components of voltage-gated sodium channels that are required for action-
potential propagation in embryonic and larval motor neurons. [89] 
 
Drosophila Husbandry 
All larvae were reared on cornmeal-molasses medium (Nutri-Fly M; Genesee 
Scientific, El Cajon, CA, USA). Each cross was reared using 6 virgin females from a driver 
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line and 3 males from either an RNAi or control line. Flies and larvae in all experiments were 
grown in a 25 °C incubator that was maintained at ∼50% humidity and set to a timed 12-hour 
light/12-hour dark cycle. Larvae for all experiments were obtained by washing wandering 
3rd instar larvae from the walls of vials using distilled water. Once washed from the vials, the 
larvae were allowed to acclimate for 3-5 minutes in a thin film of distilled water and yeast. 
Further preparation for assays is described in detail below.  
 
Thermal Nociception Assay 
Thermal nociception assays were conducted as previously described. [21] Wandering 
3rd instar larvae were washed from vials into glass petri dishes using distilled water. A small 
amount of dry baker’s yeast (3-5 mg) and ~2ml of distilled water was added to each petri 
dish. The yeast served to disrupt surface tension of the water.  Once the yeast had dissolved 
into the water, enough water was removed that only a thin film remained. Larvae were then 
stimulated along their lateral surface with a custom-built thermal probe consisting of a 
soldering iron with a tip filed into a ∼6 mm chisel shape. The custom probe was plugged into 
a Variac Variable Transformer (Part No. ST3PN1210B) (ISE, Inc., Cleveland, OH) to control 
the temperature of the probe. An IT-23 thermistor and BAT-12 digital thermometer 
(Physitemp, Clifton, NJ) was used to digitally monitor probe temperature in real time. The 
thermistor and thermometer provided temperature information to a tenth of a degree. During 
experiments, the probe tip temperature was monitored before and after application of the 
stimulus. Trials in which the probe temperature deviated from the desired temperature by 
±1 °C were discarded. Baseline thermal nociception assays were conducted at 46 ± 1 °C 
while injury-induced hypersensitization experiments tested larval thermal nociception at  
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42 ± 1 °C. Behavioral responses were recorded at 30 frames per second using a digital video 
camera mounted on a dissecting microscope. Adobe Premier Pro was used to determine the 
latency. The latency was considered to be the difference in the time it took for the larvae to 
complete NEL from the time the probe made contact with the lateral surface. Larvae that did 
not respond to the thermal stimulus within eleven seconds were scored as 11 for all 
subsequent analysis. 50 larvae were tested for each genotype in each experiment. Each cross 
was blinded to larval genotype during testing and analysis. The non-parametric Mann-
Whitney U test was used to determine statistical significance of latency differences between 
control and experimental genotypes. Bonferroni correction was used to correct the α value 
for multiple comparisons in experiments with more than one experimental group compared to 
the control. With one experimental group, an α value of 0.05 was used, while with two 
experimental groups, an α value of 0.025 was used.  
 
Mechanical Nociception Assay 
Mechanical nociception assays were conducted as previously described. [90] Larvae 
for the mechanical assays were prepped in the same fashion as the thermal assay. Mechanical 
stimulation was applied using a custom-built Von Frey filament made from 8 lb. test nylon 
fishing line (Stren Original Monofilament 8 lb. line, Part #1304152, Pure Fishing, Inc., 
Columbia, SC) measured and cut to 10 mm and taped to a Pasteur pipette. The Von Frey 
filament delivers a force of ∼50 millinewtons (mN). Each larva was stimulated with the same 
custom Von Frey filament. The NEL response was then recorded using a binary, response or 
no response system in order to calculate the percentage of larvae that responded. Each larva 
was stimulated three times. The first stimulus was the only stimulus used for scoring and 
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subsequent analyses. 100 larvae were tested per genotype in each experiment. Experimenters 
were blinded to larval genotype during stimulation. The Chi-square test was used to test for 
statistically significant differences in proportion of responders between control and 
experimental genotypes. Bonferroni correction was used to correct the α value for multiple 
comparisons in experiments with more than one experimental group compared to the control. 
With one experimental group, an α value of 0.05 was used, while with to experimental 
groups, an α value of 0.025 was used. 
 
Confocal Microscopy Assay  
Wandering 3rd instar larvae obtained from the walls of the vile using a fine tip paint 
brush and rinsed using distilled water in a petri dish. Using dissection microscope and 
forceps, the larvae were immobilized by circumferential ligation using a human hair tied 
tightly around segment A3. This method paralyzed all body segments posterior to the 
ligation. Immobilized larvae were then mounted in glycerol between two glass coverslips and 
image using confocal microscopy. A Zeiss LSM 880 microscope with a 488 nm laser line 
was used for all images. Tiled z-stacks were obtained in order to capture the full arborization 
of class IV mdda neurons from body segments posterior to the ligation. Dendrites were 
analyzed via Sholl analysis using the NeuronJ plugin for ImageJ. [91] To use this software, 
background noise from images was removed and dendrites were manually traced using 
Adobe Photoshop. Sholl Analysis creates a series of concentric circles and automatically 
quantified the average number of dendritic intersections per concentric circle as well as the 
total sum of all dendritic intersection with the concentric circles. 5-10 larvae were tested for 
each genotype in each experiment. A paired t-test was used to test for statistically significant 
 34 
differences between control and experimental conditions. An α value of 0.05 was used to 
determine statistical significance. 
 
Hypersensitization Assay 
Wandering 3rd instar larvae were washed from the walls of the vile using distilled 
water and discarded to reduce the number of pupation events during the recovery. Using 
distilled water, early 3rd instar larva and late 2nd instar larvae were washed from the food 
into a petri dish. All food and debris were removed from the larva using distilled water. The 
larvae from each genotype were then divided into separate groups (UV-exposure and NO 
UV-exposure) on separate petri dished. All petri dishes were places on ice for ~30 seconds to 
anesthetize the larvae to eliminate movement and overlap of larva during UV-exposure. The 
UV-exposure groups were placed into the UV Crosslinker and subjected to UV exposure of 
25 MJ/cm2 at 254 nm. The NO UV-exposure groups were placed into the UV Crosslinker 
and subjected to no UV. The larvae were then transferred using a fine tip paint brush to room 
temperature apple cider vinegar agar plates that had a thin film of yeast paste for recovery. 
The yeast paste was made by combining 2 parts dry Baker’s yeast with 1part distilled water. 
The recovery period occurred in the 25 °C incubator that was maintained at ∼50% humidity. 
Following an 8-hour recovery period, the larvae were washed with distilled water from the 
apple cider vinegar agar plates into a petri dish. A thermal nociception assay was then 
performed. 50 larvae were tested for each genotype under both UV and NO UV conditions.  
Larvae were tested for hypersensitization using the thermal nociception assay analysis 
method. A non-parametric Mann-Whitney U test was used to determine statistical 
significance with an α value of 0.05. 
  
 35 
 
  
Figure 7. Adapted from Brand et al. 1993. [86] Transcriptional activation of RNAi via tissue specific 
expression of GAL4 using Class IV neuron cell specific enhancer, pickpocket1.9.
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Table 1. Drosophila melanogaster stocks used for thermal, mechanical, hypersensitization, and 
confocal microscopy assays. (BDSC: Bloomington Drosophila Stock Center) (VDRC: Vienna 
Drosophila Resource Center)  
Gene Origin Genotype Notes 
ppk-GAL4; UAS-dicer-2 Dan Tracey Lab  w1118; ppk-GAL4; UAS-dicer2 GAL4 Driver 
UAS-mCD8::GFP; UAS-
dicer2 
Dan Tracey Lab UAS-mCD8::GFP; UAS-dicer2 GFP Driver 
Control for TRiP RNAi  BDSC# 36303 y1 v1; P{y+t7.7=CaryP}attP2 Negative Control  
w1118 Dan Tracey Lab w1118 Negative Control 
UAS-para-RNAi  Dan Tracey Lab 
(VDRC# 6139) 
W1118; P{UAS-para-RNAi} Positive Control 
Tor-RNAi BDSC# 33951 y1 sc* v1 sev21 P{y+t7.7 v+t1.8= 
TRiP.HMS00904}attP2 
 
Tor-RNAi BDSC# 35578 y1 sc* v1 sev21 P{y+t7.7 v+t1.8= 
TRiP.GL00156}attP2 
 
Tor-RNAi BDSC# 34639 y1 sc* v1 sev21 P{y+t7.7 v+t1.8= 
TRiP.HMS01114}attP2 
 
Lk6-RNAi BDSC# 35352 y1 sc* v1 sev21 P{y+t7.7 v+t1.8= 
TRiP.GL00264}attP2 
 
Lk6-RNAi BDSC# 28357 y1 sc* v1 sev21 P{y+t7.7 v+t1.8= 
TRiP.JF02993}attP2/TM3, Sb1 
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Results 
To better understand the role of eIF4F-regulating kinases Lk6 and Tor on post-
transcriptional regulation of proteins involved in nociception, the genes encoding Lk6 and 
Tor were knocked down in class IV mdda neurons through UAS-RNAi driven using the 
nociceptor-specific driver line ppk1.9-GAL4; UAS-dicer-2. For all experiments, two 
negative controls were used to identify the effect of each portion of the binary GAL4/UAS 
system on thermal or mechanical nociception. Each negative control tested one element of 
the binary GAL4/UAS system. The GAL4-only control, labeled ppk/+ in figures, expressed 
the ppk1.9-GAL4; UAS-dicer-2 and no UAS-RNAi. The UAS-only control, labeled UAS-
“Gene”-RNAi/+ in figures, contained the UAS-RNAi portion of the binary system with no 
ppk1.9-GAL4; UAS-dicer-2. For all thermal experiments, an increased average latency 
indicated hyposensitivity or decreased sensitivity to a noxious thermal stimulus, where a 
decreased average latency indicated hypersensitivity or increased sensitivity to a noxious 
thermal stimulus. For all mechanical experiments, an increase in the number of individuals to 
respond (% response) to a noxious mechanical stimulus indicated hypersensitivity, where a 
decrease in the number of individuals to respond (% response) to a noxious mechanical 
stimulus indicated hyposensitivity. For hypersensitization experiments, decreased average 
latency in response to a noxious mechanical stimulus indicated injury-induced 
hypersensitization via UV radiation.  
 
Lk6 knockdown does not have an effect on baseline nociceptor sensitivity 
To examine the role of Lk6 in baseline thermal nociceptor sensitivity, Lk6 was 
knocked down in Drosophila class IV mmda neurons using the GAL4/UAS system 
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previously described. Lk6 knockdown larvae using RNAi transgene BDSC# 35352 had an 
average latency of 2.79 seconds (s); Lk6 knockdown larvae using RNAi transgene BDSC# 
28357 had an average latency of 3.02 s, while the GAL4 only, UAS-Lk6-RNAi/+ (BDSC# 
35352), and UAS-Lk6-RNAi/+ (BDSC# 35352) had average latencies of 2.94 s, 3.28 s, and 
3.36 s respectively. Using a non-parametric Mann-Whitney U statistical test with an 𝛼 value 
of 0.025, it was shown that Lk6 knockdown larvae using either RNAi transgene BDSC# 
35352 or RNAi transgene BDSC# 28357 had no significant difference in latencies when 
compared to both negative controls, the GAL4 only control (p=0.385 and p=0.847) and the 
respective UAS-Lk6-RNAi controls (p=0.207 and p=0.523). Both experimental groups and 
all three negative controls have a significantly lower latency than the positive, UAS-para-
RNAi control which had an average latency of 11 s. Larvae with nociceptor-specific 
knockdown of Lk6 showed no changes in their ability to detect a noxious thermal stimulus 
(46°C). (Figure 8) 
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Figure 8. Larvae with nociceptor-specific knockdown of Lk6 showed no significant difference in their 
response latency to a noxious thermal stimulus (46°C) when compared to GAL4 only controls (ppk/+)   
as well as UAS-RNAi only negative controls. UAS-RNAi only negative controls also showed no 
significant difference in their response latency to a noxious thermal stimulus when compared to the 
GAL4 only negative control. Larvae with nociceptor-specific knockdown of para showed severely 
impaired nociceptive responses (increase latency) and were used as a positive control. Response latencies 
of individual animals are plotted as points on the graph, while the mean for each genotype is indicated as 
an enlarged point with an interval bar representing the standard error. (n = 50 for all groups; significance 
determined by non-parametric Mann-Whitney U test; α value of 0.025 was used).   
 
(46°C) 
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To examine the role of Lk6 in baseline mechanical nociceptor sensitivity, Lk6 was 
knocked down in Drosophila class IV mdda neurons using the GAL4/UAS system 
previously described. Lk6 knockdown larvae using RNAi transgene BDSC# 35352 resulted 
in 40% of the larvae responding to the noxious mechanical stimuli.  Lk6 knockdown larvae 
using RNAi transgene BDSC# 28357 resulted in 39% of the larvae responding to the noxious 
mechanical stimuli, and the GAL4 only control resulted in 51% of the larvae responding to 
the noxious mechanical stimuli. Using a Chi-square statistical test with an 𝛼 value of 0.025, 
decided using the Bonferroni correction for multiple comparisons, it was shown that Lk6 
knockdown larvae using either RNAi transgene BDSC# 35352 or RNAi transgene BDSC# 
28357 had no significant difference in % response when compared to the GAL4 only control 
(𝑝 = 0.118 and 𝑝 = 0.088). Larvae with nociceptor-specific knockdown of Lk6 showed no 
changes in their ability to detect a noxious mechanical stimulus (50 mN) when compared to 
the GAL4 only negative control. (Figure 9) 
However, when UAS-Lk6-RNAi only controls were compared with both their 
respective experimental Lk6 knockdown group and the GAL4 only control in the baseline 
mechanical assay, a significant decrease in % response was seen. UAS-Lk6-RNAi/+ (BDSC# 
35352) resulted in 19% of the larvae responding to the noxious mechanical stimuli, and had a 
significantly decreased response when compared to Lk6 knockdown larvae using RNAi 
transgene BDSC# 35352 (𝑝 = 0.001) and the GAL4 only control (𝑝 = 0.000). Similarly, 
UAS-Lk6-RNAi/+ (BDSC# 28357) resulted in 20% of the larvae responding to the noxious 
mechanical stimuli, and had a significantly decreased response when compared to Lk6 
knockdown larvae using RNAi transgene BDSC# 28357 (p	𝑝 = 0.003) and the GAL4 only 
control (𝑝 = 0.000). This result was unexpected. If the GAL4/UAS system for cell-specific 
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knockdown behaving as expected, the UAS-Lk6-RNAi only controls would not be 
significantly different than the GAL4 only negative controls. Further experimentation must 
be done to determine if Lk6 plays a role in class IV mdda neurons for baseline mechanical 
sensitivity. (Figure 9)  
  
 42 
 
 
Figure 9. Larvae with nociceptor-specific knockdown of Lk6 show no significant behavioral defect 
when compared to GAL4 only (ppk/+) negative controls. UAS-RNAi only controls showed 
significantly impaired baseline behavioral response to mechanical stimuli when compared to the GAL4 
only negative control. UAS-RNAi only negative control larvae also showed a very low response rate 
when compared to their respective nociceptor-specific Lk6 knockdown larvae. Larvae with nociceptor-
specific knockdown of para also showed a very low rate of nociceptive responses and were used as a 
positive control. (n = 100 for all groups; * indicates a significant difference when compared to the 
GAL4 only negative control; # indicates a significant difference when compared to respective UAS-
RNAi only negative controls. p < 0.025 by Chi-Square Test) 
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Lk6 knockdown mitigates effects of UV injury-induced hypersensitization 
Previous studies in mice have shown that though MNK is not involved in baseline 
nociceptor sensitivity, it may play a role in the development of hypersensitization following 
tissue damage. [31] In order to determine if Lk6 plays a role in nociceptor hypersensitization 
following tissue damage in the Drosophila model, a UV injury hypersensitization assay was 
used. [81] In this experiment, sensitivity of 3rd instar larvae to a noxious thermal stimulus 
(42°C) was tested following UV-exposure (25 MJ/cm2) and an 8-hour recovery period. The 
latency of NEL response to the thermal stimulus was quantified and analyzed as stated in the 
thermal nociception assay method. The data was categorized into percentage groups 
representing a slow, intermediate, and fast response (>10 s, 5-10 s, and <5 s) for purposes of 
visual interpretation. (Figure 10)  
 For each genotype there was a control, “NO UV”, condition and an experimental, 
“UV” condition. Like previous experiments, each nociceptor-specific knockdown of Lk6 
(ppk>Lk6-RNAi) group has two negative controls, a GAL4 only (ppk/+) and a UAS-Lk6-
RNAi only (UAS-Lk6-RNAi/+) group. Unlike previously experiments, statistical 
comparisons were only made between differing conditions of the same genotype. 
Development of hyperalgesia was determined through statistical analysis of the “UV” larvae 
versus the “NO UV” larvae of the same genotype. In the GAL4 only group, the average 
latency to respond to a noxious thermal stimulus was significantly decreased post UV 
exposure (𝑝 = 0.044). The GAL4 only group had an average response latency of 8.21 s with 
“NO UV” and 7.07 s with “UV”.  This decrease in average response latency, or increase in 
sensitivity, indicated that tissue damage induced hypersensitization did occur. The UAS-Lk6-
RNAi only control using RNAi transgene BDSC #28357 also showed an increase in 
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sensitivity (p=0.018) UAS-Lk6-RNAi/+ (BDSC# 28357) larvae with “NO UV” had an 
average response latency of 8.49 s, while UAS-Lk6-RNAi/+ (BDSC# 28357) larvae with 
“UV” had an average response of 6.91 s. The UAS-Lk6-RNAi only control using RNAi 
transgene BDSC #35352 showed a trend toward increased sensitivity however there was no 
statistical evidence (𝑝 = 0.193). UAS-Lk6-RNAi/+ (BDSC# 35352) larvae with “NO UV” 
had an average response latency of 7.95 s, while the UAS-Lk6-RNAi/+ (BDSC# 35352) 
larvae with “UV” had an average response of 6.73 s.  
 Both groups with nociceptor-specific knock of Lk6 showed no significant difference 
in sensitivity to a noxious thermal stimulus after UV induced tissue damage (BDSC# 28357 
p= 0.764; BDSC#35352 𝑝 = 0.444). Lk6 knockdown larvae with “NO UV” using RNAi 
transgene BDSC# 28357 had an average response latency of 7.88 s, while Lk6 knockdown 
larvae with “UV” using RNAi transgene BDSC# 28357 had an average response of 7.78 s.  
Lk6 knockdown larvae with “NO UV” using RNAi transgene BDSC# 35352 had an average 
response latency of 5.44 s, while Lk6 knockdown larvae with “UV” using RNAi transgene 
BDSC# 28357 had an average response of 6.01 s. This data is indicative of nociceptor-
specific knockdown of Lk6 being associated with mitigated development of injury-induced 
hypersensitization.  
 45 
  
Figure 10. Nociceptor sensitization is decreased when in larvae with nociceptor-specific knockdown of 
Lk6 post UV injury. Categorical NEL responses are represented as a percent of the total sample size (>10 
seconds for slow response; 5-10 seconds for intermediate response; <5 for fast response). Larvae from 
the GAL 4 only (ppk/+) control group became more sensitive to a noxious thermal stimulus (42°C) and 
had a significantly reduced response latency post UV exposure. Larvae from the Lk6-UAS-RNAi 
(BDSC# 35352) only control for did not become sensitive to a noxious thermal stimulus (42°C) post UV 
exposure and showed no significant difference in latency when compared to the larvae without UV 
exposure. Larvae with nociceptor-specific knockdown of Lk6 (BDSC# 35352) showed no significant 
difference in their response latency to a noxious thermal stimulus (42°C) post UV exposure when 
compared to larvae with nociceptor-specific knockdown of Lk6 (BDSC# 35352) without UV exposure. 
Larvae from the Lk6-UAS-RNAi (BDSC# 28357) only control became more sensitive to a noxious 
thermal stimulus (42°C) and had a significantly reduced response latency post UV exposure when 
compared to Lk6-UAS-RNAi (BDSC# 28357) larvae without UV exposure. Larvae with nociceptor-
specific knockdown of Lk6 (BDSC# 28357) showed no significant difference in their response latency to 
a noxious thermal stimulus (42°C) post UV exposure when compared to larvae with nociceptor-specific 
knockdown of Lk6 (BDSC# 28357) without UV exposure 
 
> 10 seconds 
5-10 seconds 
< 5 seconds 
 
 
 
Legend 
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Lk6 knockdown has no effect on nociceptor development  
Defects in nociception and hypersensitization can potentially arise from defects in 
morphological development of class IV mdda neurons. Therefore, it was important to 
identify whether nociceptor-specific knockdown of Lk6 was associated with any defects in 
dendritic complexity. To determine if defects in nociceptor plasticity in Lk6 knockdown 
larvae stemmed from developmental defects, the expression of GFP and Lk6 knockdown in 
class IV neurons was driven by ppk1.9-GAL4>mCD8::GFP;UAS-dicer 2. Live cell confocal 
microscopy images (Figure 11A/B) were prepared in Adobe Photoshop and analyzed using 
Sholl analysis. Sholl analysis provides quantitative information regarding the complexity of 
dendrites through methods involving the measurement of interaction of dendrites with a 
series of concentric circles. (Figure 11C/D)  
Control (y1 v1; P{y+t7.7=CaryP}attP2) larvae expressing GFP had an average of 
26,185.5 total dendritic interactions while Lk6 knockdown larva (BDSC# 35352) has an 
average of 29,515.9 total dendritic interactions (p=0.553). (Figure 11E) Control (y1 v1; 
P{y+t7.7=CaryP}attP2) larvae expressing GFP had an average of 22.4 mean dendritic 
interactions while Lk6 knockdown larva (BDSC# 35352) has an average of 26.7 mean 
dendritic interactions (𝑝 = 0.112). Significance determined by a paired t-test revealed that 
nociceptor-specific knockdown of Lk6 was not associated with any development defects of 
class IV neurons. (Figure 11F) 
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Figure 11. (A, B) Confocal micrographs displaying the dendritic arborization of class IV mdda neurons 
expressing mCD8::GFP in wild-type and Lk6-RNAi. (C, D) Tracings of dendritic arborizations of 
confocal micrographs displaying the dendritic arborization of class IV mdda neurons expressing 
mCD8::GFP in wild-type and Lk6-RNAi. (E, F) Sholl analysis of dendritic arborization of class IV 
mdda neurons expressing mCD8::GFP in wild-type and Lk6-RNAi. Nociceptor-specific knockdown 
of Lk6 had no effect on larval dendritic complexity. No significant difference was seen in the total 
dendritic intersections or the average dendritic intersections of larvae with nociceptor-specific 
knockdown of Lk6 when compared to the arbors of wild-type class IV mdda neurons.    
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Tor knockdown may result in increased baseline thermal nociceptor sensitivity 
To examine the role of Tor in baseline thermal nociceptor sensitivity, Tor was 
knocked down in Drosophila class IV mdda neurons using the GAL4/UAS system 
previously described. Tor knockdown larvae using RNAi transgene BDSC# 33951 had an 
average latency of s; Tor knockdown larvae using RNAi transgene BDSC# 35578 had an 
average latency of 5.28 s, while the GAL4 only control had an average latency of 2.85 s. 
Both Tor knockdown groups were significantly less sensitive to the noxious thermal stimulus 
than the GAL4 only control (𝑝 = 0.000). These results indicated that larvae with nociceptor-
specific knockdown of Tor showed increased sensitivity to a noxious thermal stimulus 
(46°C). However, UAS-Tor-RNAi only controls did not behave as expected. UAS-Tor-
RNAi/+ (BDSC# 33951) had a significantly greater response latency (6.47 s) than the GAL4 
only control (p=0.000) and was not significantly different from larvae with nociceptor-
specific knockdown of Tor using RNAi transgene BDSC# 33951 (p=0.005). UAS-Tor-
RNAi/+ (BDSC# 35578) had a significantly greater response latency (6.67 s) than the GAL4 
only control (p=0.000) and was not significantly different from larvae with nociceptor-
specific knockdown of Tor using RNAi transgene BDSC# 35578 (p=0.016). Both 
experimental groups and all three negative controls had a significantly lower latency than the 
positive, UAS-para-RNAi, control which had an average latency of 11 s. In this experiment a 
non-parametric Mann-Whitney U statistical test with an 𝛼 value of 0.025 was used. Trends 
show that larvae expressing the Tor-RNAi transgene are less sensitive to noxious thermal 
stimuli. (Figure 12) 
In attempt to gain insight into nociceptor-specific knockdown of Tor on baseline 
thermal nociception, the experiment was repeated using a different transgenic Tor-RNAi line 
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(BDSC# 34639). Tor knockdown larvae using RNAi transgene BDSC# 34639 had an 
average latency of 4.14 s. Tor knockdown larvae using RNAi transgene BDSC# 34639 did 
not show any significant differences when compared to the GAL4 only control which had an 
average response latency of 3.10 s (p=0.334) or the UAS-Tor-RNAi only control which has 
an average response latency of 4.44 s (p=0.068). The experimental group and both negative 
controls had a significantly lower latency than the positive, UAS-para-RNAi, control which 
had an average latency of 11 s. In this experiment a non-parametric Mann-Whitney U 
statistical test with an 𝛼 value of 0.05 was used. The trends in this experiment do not align 
with other experiments using UAS-Tor-RNAi transgenes making it difficult to interpret the 
results of the experiments altogether. This experiment was unable to confirm the results 
generated using RNAi transgene BDSC# 33951 or RNAi transgene BDSC# 35578.  
(Figure 13) 
  
 50 
 
  
Figure 12. Larvae with nociceptor-specific knockdown of Tor showed significantly increased sensitivity 
(increased latency) to a noxious thermal stimulus (46°C) when compared to the GAL4 only (ppk/+)   
negative control. UAS-RNAi only negative controls also showed significantly increased sensitivity 
(increased latency) to a noxious thermal stimulus when compared to the GAL4 only negative control. 
Larvae with nociceptor-specific knockdown of Tor showed no significant difference in their response 
latency to a noxious thermal stimulus (46°C) when compared to their respective UAS-RNAi only control. 
Larvae with nociceptor-specific knockdown of para showed severely impaired nociceptive responses 
(increase latency) and were used as a positive control. Response latencies of individual animals are 
plotted as points on the graph, while the mean for each genotype is indicated as an enlarged point with an 
interval bar representing the standard error. (n = 50 for all groups; significance determined by non-
parametric Mann-Whitney U test; α value of 0.025 was used).   
 
(46°C) 
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Figure 13. Larvae with nociceptor-specific knockdown of Tor showed no significant difference in their 
response latency to a noxious thermal stimulus (46°C) when compared to the GAL4 only (ppk/+) 
negative control. Larvae with nociceptor-specific knockdown of Tor showed no significant difference in 
response latency to a noxious thermal stimulus (46°C) when compared to the respective UAS-RNAi only 
negative control. Larvae with nociceptor-specific knockdown of para showed severely impaired 
nociceptive responses (increase latency) and were used as a positive control. Response latencies of 
individual animals are plotted as points on the graph, while the mean for each genotype is indicated as an 
enlarged point with an interval bar representing the standard error. (n = 50 for all groups; significance 
determined by non-parametric Mann-Whitney U test; α value of 0.05 was used).   
 
(46°C) 
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To examine the role of Tor in baseline mechanical nociceptor sensitivity, Tor was 
knocked down in Drosophila class IV mdda neurons using the GAL4/UAS system 
previously described. Tor knockdown larvae using RNAi transgene BDSC# 33951 resulted 
in 50% of the larvae responding to the noxious mechanical stimuli, Tor knockdown larvae 
using RNAi transgene BDSC# 33951 resulted in 33% of the larvae responding to the noxious 
mechanical stimuli, and the GAL4 only control resulted in 51% of the larvae responding to 
the noxious mechanical stimuli. It was found that Tor knockdown larvae using RNAi 
transgene BDSC# 33951 were not significantly different from the GAL4 only control 
(p=0.888), while the Tor knockdown larvae using RNAi transgene BDSC# 35578 were 
(p=0.010). (Figure 14) 
In addition, when UAS-Tor-RNAi only controls were compared with both their 
respective experimental Tor knockdown group and the GAL4 only control in the baseline 
mechanical assay, a significant decrease in % response was seen. UAS-Tor-RNAi/+ (BDSC# 
33951) resulted in 11% of the larvae responding to the noxious mechanical stimuli, and had a 
significantly decreased response when compared to Tor knockdown larvae using RNAi 
transgene BDSC# 33951 and the GAL4 only control (𝑝 = 0.000). Similarly, UAS-Tor-
RNAi/+ (BDSC# 35578) resulted in 9% of the larvae responding to the noxious mechanical 
stimuli, and had a significantly decreased response when compared to Tor knockdown larvae 
using RNAi transgene BDSC# 35578 and the GAL4 only control (𝑝 = 0.000). This result 
was unexpected. If the GAL4/UAS system for cell-specific knockdown behaved as expected, 
the UAS-Tor-RNAi only controls would not be significantly different than the GAL4 only 
negative controls. Larvae with nociceptor-specific knockdown of Tor showed inconsistent 
responses when observing their ability to detect a noxious mechanical stimulus (50 mN) in 
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comparison to the GAL4 only negative control. Further experimentation must be done to 
determine if Tor plays a role in class IV mdda neurons for baseline mechanical sensitivity. 
(Figure 14)  
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Figure 14. No conclusive trends in behavioral response are seen in larvae with nociceptor-specific 
knockdown of Tor. UAS-RNAi only negative controls showed significantly impaired baseline behavioral 
responses to mechanical stimuli as did knockdown of BDSC# 35578 when compared to the GAL4 only 
(ppk/+) negative control. Larvae with nociceptor-specific knockdown of para also showed a very low 
rate of nociceptive responses and were used as a positive control. (n = 100 for all groups; * indicates a 
significant difference when compared to the GAL4 only negative control; # indicates a significant 
difference when compared to respective UAS-RNAi only negative controls. p < 0.025 by Chi-Square 
Test) 
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Tor knockdown is associated with a slight increase in dendritic complexity  
Because defects in nociception can potentially arise from defects in morphological 
development of class IV mdda neurons, it was important to identify whether nociceptor-
specific knockdown of Tor was associated with any defects in dendritic complexity. To 
determine if defects in nociceptor plasticity in Tor knockdown larvae stemmed from 
developmental defects, the expression of GFP and Tor knockdown in class IV neurons was 
driven by ppk1.9-GAL4>mCD8::GFP;UAS-dicer 2. Live cell confocal microscopy images 
(Figure 15A/B) were prepared in photoshop and analyzed using Sholl analysis. Sholl analysis 
provides quantitative information regarding the complexity of dendrites through methods 
involving the measurement of interaction of dendrites with a series of concentric circles. 
(Figure 15C/D)  
Control (y1 v1; P{y+t7.7=CaryP}attP2) larvae expressing GFP had an average of 
29,350.2 total dendritic interactions while Tor knockdown larva (BDSC# 33951) had an 
average of 33,338.8 total dendritic interactions (𝑝 = 0.121). (Figure 15E) There was no 
significant difference in the total number of dendritic interactions, however when the mean 
dendritic interactions were compared, it was discovered that larvae with nociceptor-specific 
knockdown of Tor showed increased dendritic complexity when looking at the mean 
dendritic interactions. Control (y1 v1; P{y+t7.7=CaryP}attP2) larvae expressing GFP had an 
average of 21.64 mean dendritic interactions while Tor knockdown larva (BDSC# 33951) 
has an average of 26.12 mean dendritic interactions (𝑝 = 0.018). Significance determined 
using a paired t-test revealed that nociceptor-specific knockdown of Tor was associated with 
a slight increase in dendritic complexity and may play a role in the development of class IV 
nociceptive neurons.  (Figure 15F) 
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Figure 15. (A, B) Confocal micrographs displaying the dendritic arborization of class IV mdda 
neurons expressing mCD8::GFP in wild-type and Tor-RNAi. (C, D) Tracings of dendritic 
arborizations of confocal micrographs displaying the dendritic arborization of class IV mdda neurons 
expressing mCD8::GFP in wild-type and Tor-RNAi. (E, F) Sholl analysis of dendritic arborization of 
class IV mdda neurons expressing mCD8::GFP in wild-type and Tor-RNAi. Larvae with nociceptor-
specific knockdown of Tor showed a small increase in dendritic complexity. No significant difference 
was seen in the total dendritic intersections of larvae with nociceptor-specific knockdown of Tor 
while they did display a significant increase in the average number of dendritic intersections when 
compared to the arbors of wild-type class IV mdda neurons.    
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Discussion 
The activity-dependent regulation of protein synthesis is a core mechanism mediating 
neuronal plasticity. In the nociceptive system, it has been demonstrated that translation 
regulation pathways contribute to both the development and maintenance of chronic pain, 
which suggests that targeting these pathways may lead to new therapeutic treatments for 
chronic pain. Though synaptic plasticity is initially mediated by changes in protein 
trafficking, translation of synaptic mRNAs is required for structural changes in the synapse 
and maintenance of altered neurotransmission. [92] Protein synthesis is primarily regulated 
via translation initiation, which requires the binding of eIF4E to the 5’ cap of the mRNA. 
[93] Binding of eIF4E to the 5’ cap recruits eIF4G to eIF4E in a process that facilitates 
ribosome binding. eIF4G provides a scaffold for the binding of eIF4A to form the eIF4F 
complex. [94] MNK and mTOR are able to regulate translation initiation by influencing the 
capacity of eIF4E to bind to the 5’ cap. [95] Different translation regulation targets have been 
shown to play very unique roles in controlling different aspects of pain sensitivity. For 
example, loss of 4E-BP1 leads to changes in the availability of cell-adhesion molecule, 
neuroligin 1, resulting in changes in mechanical sensitivity [96], while a mutation in eIF2𝛼 
that inhibits phosphorylation results in changes in baseline thermal nociception with no 
changes in mechanical sensitivity [97]. Collectively, these studies suggest that individual 
translation regulation pathways may target specific subsets of mRNAs that have profound 
impacts on certain aspects of nociception. Translation regulation pathways that include the 
upstream signaling factors, mTOR and MNK, have been shown to play a role in nociceptive 
plasticity using both biochemical and pharmacological measures. [17, 31, 98] 
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In order to establish a model to study the impact of Lk6 and Tor expression on 
nociception, the GAL4/UAS system was used to knockdown each kinase in the nociceptors. 
Because Lk6 and Tor use different mechanisms to influence eIF4E availability in translation 
initiation, it was hypothesized that each kinase would be important in controlling different 
aspects of nociceptor sensitivity. It was hypothesized that knockdown of Tor would result in 
decreased baseline nociceptor sensitivity and decreased morphological complexity of 
nociceptors. [21, 99]  It was hypothesized that knockdown of Lk6 would have no effect on 
baseline sensitivity or morphological complexity in nociceptors, while development of tissue 
injury induced hypersensitivity would be affected. [17, 28, 31, 32, 100] 
Knockdown of Lk6 resulted in phenotypic changes that supported the proposed 
hypothesis. Knockdown of Lk6 had no effect on baseline thermal nociceptor sensitivity. 
Knockdown of Lk6 appeared to have no effect on baseline mechanical nociceptor sensitivity, 
however, due to differences between the UAS-Lk6-RNAi negative controls and GAL4 only 
controls further experimentation must be done to confirm the role of Lk6 in mechanical 
nociceptor sensitivity. Knockdown of Lk6 had no effect on nociceptor morphology. And 
lastly, knockdown of Lk6 was able to mitigate the effects of hypersensitization following 
UV-induced tissue damage. These results suggest the probable conclusion that Lk6 function 
is not needed for nociceptor growth or baseline function, but it may have an important role in 
regulation of protein synthesis during hypersensitization. This suggest that specific mRNA 
transcripts are being more highly regulated by Lk6 than others. It is probable that the mRNA 
transcripts whose translation plays a role in hypersensitization and are affected by Lk6 fall in 
the category of eIF4E sensitive mRNAs. (Table 2) 
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The finding that knockdown of Tor had decreased baseline thermal nociceptor 
sensitivity (thermal hyposensitivity) aligned with the proposed hypothesis, however, 
unexpected decreases in the sensitivity of the UAS-Tor-RNAi negative control compared to 
the GAL4-only control indicated that the hyposensitive phenotype could not be confidently 
attributed to a cell-specific knockdown of Tor in the nociceptors. It was also unexpected that 
knockdown of Tor resulted in a slight increase in morphological complexity of the dendrites 
in class IV mdda neurons. This knockdown morphological result could be confirmed through 
additional controls such as an UAS-Tor-RNAi negative control to ensure that the 
morphological defects can be attributed to nociceptor-specific knock down of Tor.  
Knockdown of Tor illuminated no conclusive trends in baseline mechanical nociceptor 
sensitivity due to significant difference in UAS-Tor-RNAi negative control and GAL4 only 
negative controls indicating that further experimentation must be done to confirm these 
results. These results suggest the probable conclusion that Tor plays a role in baseline 
thermal nociception function, and likely has an important role in regulating the expression of 
genes required in thermal nociception at a baseline level and perhaps in cases of 
hypersensitization. (Table 2) 
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Table 2. Summary of experimental outcomes of thermal and mechanical baseline nociception, UV-
hypersensitization, and confocal microscopy assays (N/A indicates no experiment done) (BDSC- Bloomington 
Drosophila Stock Center). 
 
Gene RNAi 
BDSC# 
Thermal 
Phenotype 
Mechanical 
Phenotype 
Hypersensitivity 
Phenotype 
Morphological 
Phenotype 
Lk6 35352 No Change No Change 
(UAS only control 
inconclusive) 
Hypersensitization 
Diminished 
(UAS only control 
inconclusive) 
 
 
No Change 
Lk6 28357 No Change No Change 
(UAS only control 
inconclusive) 
 
Hypersensitization 
Diminished 
 
 
 
N/A 
Tor 33951 Hyposensitive Inconclusive N/A 
 
 
 
 
Increased 
Complexity 
Tor 35578 Hyposensitive Inconclusive N/A 
 
 
 
 
N/A 
Tor 34639 No Change N/A N/A N/A 
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 Lk6 Does Not Affect Basal Translation of Proteins Involved in Nociception 
The Drosophila genome contains a single MNK homolog, Lk6. [101] Lk6 is activated 
through phosphorylation by ERK but not by p38 MAPK signaling. Lk6, when activated, 
phosphorylates eIF4E at Ser251 [101], which is analogous to Ser209 in mammals, the 
residue that is phosphorylated by MNK. [102] The exact mechanism by which the 
phosphorylation of eIF4E enhances translation is not well developed. Early studies depicted 
that phosphorylated eIF4E has an enhanced binding affinity for the 5’ cap [103], while other 
studies were able to show MNK-induced phosphorylation of eIF4E reduced binding affinity 
for the 5’ cap. Reduced binding affinity may result in the disruption of the interaction 
between eIF4E and the 5’ cap, which in turn would increase translation rates by increasing 
the availability of eIF4E in order to enable addition rounds of translation initiation. Though 
both mechanisms would act to positively enhance translation rates through, it has been found 
that MNK is not necessary for basal rates of cap-dependent translation to occur. [104] 
Though there are limited studies regarding the role of Lk6 in baseline nociceptor 
sensitivity, many mammalian studies have focused on the role of MNK in a post-injury 
scenario. In most studies, mammals with a mutation in Ser209, the MNK phosphorylation site 
on eIF4E, or mutations resulting in complete loss of function of MNK were used to decrease 
the function or availability of MNK proteins. In these studies, it was found that there was no 
difference between mutants and controls when looking at baseline thermal and mechanical 
nociceptor sensitivity [31, 98]. This information led the hypothesis that MNK does not play a 
role in baseline thermal or mechanical nociceptor sensitivity. Evidence gathered from the 
research conducted supports the hypothesis that phosphorylation of eIF4E by Lk6 is not 
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required for baseline thermal or mechanical nociception and the conclusion that regulation of 
translation through Lk6 has no effect on baseline nociceptor sensitivity.  
To provide further evidence for the role of Lk6 in baseline nociceptor function, 
morphological analysis of dendrites lacking Lk6 in the class IV mdda neurons was done. It 
was found that larvae lacking the eIF4E kinase, Lk6, successfully developed dendritic arbors 
of normal complexity. Previous studies have shown conflicting data regarding the role of 
eIF4E phosphorylating kinases in the development of both insects and mammals.  In mice, it 
has been shown that knockout of MNK1, MNK2 or both resulted in offspring that were 
viable, fertile, and developed normally, indicating that eIF4E phosphorylation is not essential 
for growth and development. [105] However, studies in Drosophila provide evidence that 
phosphorylation of eIF4E by Lk6 is vital for development. Mutation of ser251, the Lk6 
phosphorylation site on eIF4E, in Drosophila resulted in reduced viability, slower 
development, and reduced adult size, demonstrating that phosphorylation of eIF4E is 
required for normal organismal growth. [106] In this study, it was hypothesized that Lk6 is 
not involved in the development of nociceptive neurons as they appeared to function 
normally in the behavioral assays for baseline nociception. The findings support the 
hypothesis. It was found that no developmental defects were found in the class IV mdda of 
Drosophila larvae with nociceptor-specific knockdown of Lk6. These findings align with 
mammalian studies that indicate eIF4E phosphorylation is not essential for growth and 
development, however, because the knockdown of Lk6 was limited to nociceptors, 
developmental defects caused by genome-wide loss of Lk6 are still probable.  
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Evidence from morphological analysis and baseline behavioral nociception assay 
indicate that Lk6 does not cause any significant changes in translation of proteins that are 
necessary for normal nociception from both the molecular and structural standpoint.  
 
Lk6 Regulates Synthesis of Proteins Required for Nociceptor Sensitization  
To further investigate the role of Lk6 in translation regarding nociception, an injury-
induced hypersensitization model using UV radiation was used to determine if Lk6 regulates 
synthesis of proteins required for neural plasticity. The proper localization and synthesis of 
proteins is essential for synaptic plasticity. Synaptic plasticity requires the translation of 
proteins that modulate synapse function. [107]  Although synaptic plasticity is initially 
mediated by changes in protein trafficking, translation of synaptic mRNAs is required for 
structural changes to the synapse and to maintain states of chronic pain. [92] Synaptic 
translation initiation is believed to be mediated via mTOR and MNK signaling pathways, 
downstream of ERK. 
Many studies are in agreement that both mTOR and MNK are required for nociceptor 
hypersensitivity following tissue damage. Studies in mice have developed a compelling case 
for MNK signaling as a core signaling pathway in the generation of thermal and mechanical 
hypersensitivity as well as ongoing pain in response to inflammation. [31, 53] Mice that have 
a mutation at the MNK phosphorylation site on eIF4E show have defective development of 
nociceptive behavioral plasticity in response to inflammatory mediators such as NGF and fail 
to show increased nociceptor excitability in response to these mediators. [98] The experiment 
done in this study, on Drosophila larvae with nociceptor-specific knockdown of Lk6, show 
conclusive results that knockdown of Lk6 was able to stop the development of thermal 
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hypersensitivity after injury induced by UV radiation. This signaling mechanism has been 
show to function similarly in studies of chronic pain development in both the fly and mouse 
models.  
This model can be used to help understand the transition from acute to chronic pain, 
where blocking eIF4E phosphorylation could be a primary target in blocking the transition to 
a chronic pain state after injury. In mammals, phosphorylation of eIF4E by MNK is known to 
regulate the translation of a number of mRNA transcripts that are involved in nociceptive 
plasticity. These mRNA transcripts include matrix metalloprotease 9 (MMP9) which has 
shown to be upregulated in cases of autism causing alterations in synaptic plasticity and 
dendritic spine morphogenesis, [108] brain-derived neurotrophic factor (BDNF) which has 
been shown to regulate mediate hyperalgesic priming in the mammalian dorsal root ganglion 
(DRF) [100], and many cytokines and chemokines that are involved in pain signaling. 
Similar results have been shown in Drosophila, where the Lk6-eIF4E signaling pathway has 
been shown to modulate the availability of molecules necessary for sensitization, including 
molecules that modulation neural transmission such as glutamate and its receptors.  [18, 52] 
Another potential translational target of the MNK-eIF4E signaling pathway is 
glutamate receptor, GluRIIA. Glutamate is known to mediate the majority of the 
neurotransmission in the CNS in mammals. Following the establishment of a synapse, its 
strength can be modified by changes in synaptic size, presynaptic glutamate release, and the 
number of post synaptic glutamate receptors. The capacity of the synapse to change during 
nociceptor plasticity requires regulated expression of glutamate receptors, such as GluRIIA, 
by pathways such as the MNK-eIF4E signaling pathway to modulate synapse strength. 
Previous studies done in Drosophila show that Lk6, the Drosophila homolog of MNK, is 
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required proper localization of GluRIIA in both pre and post synaptic neurons. Lk6 likely 
signals through eIF4E to regulate the synaptic levels of GluRIIA. It has been shown that 
disrupting the binding of eIF4E to eIF4G or inducing the expression of a non-
phosphorylatable isoform of eIF4E results in a significant reduction in GluRIIA at the 
synapse and this reduced neural transmission. This evidence suggests that proper expression 
of GluRIIA is necessary for proper neural transmission and its expression is potentially 
regulated by the Lk6-eIF4E signaling pathway during the development of neural plasticity. 
However, the role of glutamate in Drosophila nociception has yet to be discovered.  [18] 
A hallmark of peripheral sensitization is increased thermal sensitivity which is known 
to be supported by ERK (the molecule known to phosphorylate and activate MNK) activation 
and subsequent synthesis of proteins and ion channels necessary for nociception. [87] Studies 
in mice have shown that pharmacologic inhibition and genetic inactivation of ERK disrupted 
the function of TMEM16A. TMEM16A is a receptor-activated calcium-dependent chloride 
channel that is analogous to anoctamin 1 (ANO1). [109] It has been shown that interaction 
between ANO1 and TRPV1, a thermally sensitive calcium channel, causes strengthened 
action potentials that result in strong pain sensations. Peripheral sensitization is commonly 
understood to be mitigated by increased thermal sensitivity which is thought to be supported 
by ERK activation a subsequent synthesis of the TRPV1 receptor and its transport to the 
axon terminals in damages tissue. [17] There was also a correlation between the expression 
levels of Nav1.7, a sodium channel known to pay a role in nociception, ERK, and the degree 
of inflammatory pain. Inhibition of Nav1.7 causes a decline of ERK expression and Nav1.7 
protein levels were also increased with increased phosphorylation of ERK. [110] With this 
information, it is evident that the ERK-MNK-eIF4E phosphorylation pathway plays a role in 
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the development of nociceptor and potentially by many different and complex mechanism. 
Because, ERK signaling to downstream effectors, MNK (in mammals) or Lk6 (in Drosophila) 
has a well characterized effect of the development of hypersensitization, the hypothesis that 
Lk6 will regulate the expression of factors such as GluRIIA and ion channels that are 
necessary for hypersensitization, and when knocked down, Lk6 will not be able to produce 
hypersensitive phenotypes.  
 
Tor May Effect Baseline Nociception and Likely Plays a Role in Hypersensitization 
Tor is considered to be a vital component in positive translation regulation through 
control of downstream effector eIF4E via phosphorylation of 4E-BP1and has been shown to 
play a role in cell growth and the control of hypersensitivity following injury. mTOR has 
been shown to be necessary for the development of thermal hypersensitivity following tissue 
injury in mice. Surgical procedures, such as plantar incision, facilitate production of 
algogenic and/or hyperalgesic molecules, leading to peripheral sensitization. Similar to 
hypersensitization studies done with MNK, it was shown that thermal sensitivity induced by 
tissue-damage, in this case plantar incision, was mediated through another regulator of 
glutamate, vesicular glutamate transporter 2 (VGLUT2). The expression of VGLUT2 along 
with thermal hypersensitivity was reduced when mTOR was inhibited using rapamycin. This 
suggest that mTOR does play a role in the development of hypersensitization and perhaps 
through modulation of the expression of molecules involved in neurotransmission such as 
glutamate, a phenomenon also seen downstream of the MNK-eIF4E signaling axis. [111]  
Mice models have shown that mTOR plays a role in proper sensory transmission of 
noxious stimuli. Vertebrate primary afferent nociceptors can be divided into A𝛿 fibers, that 
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are myelinated and mediate the first sensation of sharp and rapid pain, and C fibers that are 
unmyelinated and sense secondary delayed or diffused pain. [17] Studies utilizing the mTOR 
inhibitor, rapamycin, showed reduced sensitivity that acted in part by reducing the sensitivity 
of A𝛿 fibers that are responsible for the “first” or fast pain produced by a noxious thermal 
stimulus. Inhibition of mTOR did change the electrical excitability of slow transduction C 
fibers. [21]  This suggest that Tor could be used to reduce the initial pain generated by a 
noxious stimulus through reduction in the function of A𝛿 fiber function, however whether 
this phenomenon occurs independently of inflammation or prior injury is unknown. In 
opposition to this hypothesis it has been shown that mTOR is not required for baseline 
nociceptor sensitivity. Chronic systemic treatment with CCI-779 (a rapamycin analog) 
inhibited the mTOR pathway in sensory axons reducing mechanical and cold hypersensitivity 
after peripheral nerve injury without affecting the nociceptive threshold in naive controls 
[87]. Conflicting and unclear conclusions regarding the role for mTOR in baseline 
nociception supports the need for continued research on translational control of genes 
involved in nociception. For the presented research, it was hypothesized that mTOR would 
be important in baseline nociception given its reputation of the master regulator translation 
initiation. [17] 
In this study, it was found that nociceptor-specific knockdown of Tor in Drosophila 
resulted in decreased thermal nociceptor sensitivity. During the thermal assay conducted at 
46℃, decreased nociceptor sensitivity, was seen not only in the experimental Tor knockdown 
groups but also in RNAi-only groups that controlled for insertion of the RNAi transgene. 
These results indicated that while interruption of the Tor gene may cause defects in the larval 
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ability to detect a noxious stimulus, it cannot be specifically attributed to cell-specific 
knockdown.  
Morphological analysis of nociceptors lacking Tor in Drosophila showed a slight 
increase in dendritic complexity when looking at the average of dendritic intersections, 
however, this phenomenon was not seen when looking at the total number of dendritic 
intersections using Sholl analysis. This result is unexpected and cannot be fully attributed to 
nociceptor-specific knockdown of Tor given inconclusive controls found in mechanical and 
thermal assays. mTOR is known to be involved in signaling pathways that control 
cell growth, nutrient metabolism, and protein translation. mTOR regulates many functions in 
the development of the brain, such as proliferation, differentiation, cell migration, 
and dendrite formation. In addition, mTOR is important in synaptic formation and plasticity. 
Abnormalities in mTOR activity is linked with severe deficits in nervous 
system development, including tumors, autism, and seizures. mTOR signaling pathways are 
essential to neurogenesis and the establishment of neural circuits. In order to further 
investigate the morphological results found in this experiment, additional controls, such as a 
UAS-Tor-RNAi negative control, controlling for insertion of the RNAi transgene would be 
needed to attribute any changes in class UV mdda neurons to loss of function of Tor.  
[99] 
Inconclusive results were found through mechanical nociception assay following 
nociceptor-specific knockdown of Tor. The experimental Tor knockdown group showed 
trends that indicated that the expression of Tor has no effect on baseline mechanical 
nociception; one experimental group did not differ from the GAL4 only control and the other 
varied only slightly from the GAL4 only control. Significant differences between the UAS-
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Tor-RNAi only negative controls GAL4 only control and the other varied only slightly from 
the GAL4 only control, while groups controlling for the transgene insertion showed reduced 
mechanical sensitivity. The results of the mechanical experiment were, therefore, rendered 
inconclusive. Though the results were inconclusive, the trends align with previous literature 
that suggest that translation control of mTOR has no effect of nociceptors ability to detect a 
noxious mechanical stimulus. Studies utilizing mice models have shown that inhibition of 
mTOR using rapamycin showed no change in the expression of proteins, such VGLUT3, a 
glutamate transporter known to be required in mechanical nociception, but did show 
increases in VGLUT2, a glutamate transporter known to be involved in thermal nociception 
via expression with TRPV1, an ion channel shown to responsible for thermal signal 
transduction. These studies could suggest that similar mechanism could be functioning to 
regulate the translation of thermally sensitive Drosophila TRP channels such as TRPA1. 
[111-114] 
 
Tor Transgenic Drosophila Lines Revealed Inconsistencies Between Negative Controls 
Throughout the mechanical and thermal assays, difference between the GAL4 only 
and UAS-RNAi controls were seen. These negative controls are important as they control for 
and behavioral effects caused by individual aspects of the GAL4/UAS-RNAi system. When 
comparing GAL4 only controls to UAS-RNAi only controls it is expected that they will not 
be significantly different to one another. In order to address the problem between negative 
control groups within the mechanical assay of both Tor and Lk6 knockdown, a revised 
mechanical assay could be used. Stimulation with a Von-Frey filament could remain a 
noxious stimulus while behavioral responses could be more robustly analyzed. In this 
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experiment only NEL was quantified. However, it has been shown that Drosophila larva 
exhibit multiple behavioral responses to noxious stimuli. Drosophila larvae typically have a 
distinct response to thermal nociception, a corkscrew-like roll toward or away from the 
stimulus. This response is typically proceeded by c-shaped body bending, however at times 
the body bend is sufficient for noxious stimuli relief and will not be followed by NEL; this 
escape method is termed “bending”. [115] . Noxious mechanical stimuli have also been 
shown to cause head casting and head retraction in Drosophila larvae. [116]  Behavioral 
screens in Drosophila have also identified mutations that cause a “bang-sensitive” (BS) 
behavioral phenotype, that is, they paralyze and seize following mechanical stimulation. One 
mutant was shown to exhibit neuronal hyperexcitability and paralysis for ∼20 seconds when 
subjected to mechanical stimuli. [117, 118] This behavioral phenotype was observed but not 
quantified during the mechanical assay for nociceptor-specific knockdown of Lk6. A more 
robust video analysis of the behaviors exhibited by Drosophila larva with nociceptor-specific 
knockdown could perhaps illuminate conclusive effects of the genes on translation and 
nociception.  
 However, robustness of the thermal assay is not a probable cause of differences seen 
between negative control groups as the delivery of the stimulus and method of analysis is 
highly regulated. When comparing GAL4 only controls to UAS-RNAi only controls it is 
expected that they will not be significantly different to one another. The currently lines 
cannot draw conclusive results due to significant difference in the negative control groups. In 
order to further investigate the role of Tor in translation and nociception, experimental 
transgenic lines and their controls that act appropriately must be found or created. The 
differences that have been observed between GAL4 only controls and UAS-RNAi only 
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controls could be due to off-target effects, though the GAL4/UAS system effectively reduced 
the probability of off-target effects, or the insertion of the transgene could have caused 
defects in the chromosome. In order to move forward, transgenic lines could be ordered from 
Vienna Drosophila Resource Center (VDRC) and tested to see if groups controlling for 
RNAi transgene insertion would react more similarly to GAL4 only controls. Dominant-
negative mutations have also been used extensively in flies with the GAL4/UAS system, an 
alternative to RNAi-mediated gene knockdowns to disrupt gene activity. Dominant-negative 
versions of the protein of interest provide an independent means to confirm that effects 
obtained with such molecules accurately represents loss of function phenotypes. Lastly, 
down steam targets could be specifically mutated in ways that mimic the loss of function of 
their upstream regulator. For example, lines that have mutations in 4E-BP at the 
phosphorylation site of Tor could be used to analyze the role of Tor.  
 
Future Directions 
 In the future, conclusive results for Lk6 knockdown in mechanical nociception will be 
found. Experiments looking at the phosphorylation status of eIF4E following knockdown of 
Lk6 would be useful in confirming the role of Lk6 in the nociceptive neurons of Drosophila. 
It would also be useful to look at general translation rates and the changes that occur 
following Lk6 knockdown. Discrepancies in Tor transgenic lines will be elucidated and 
conclusive baseline mechanical and thermal nociception effects will be found, hopefully 
through the use of new transgenic lines obtained from the Vienna Drosophila Resource 
Center.  Further, because it is hypothesized that Tor will play a role in both baseline 
nociception and the development of injury induced hypersensitization, a tissue injury induced 
 72 
hypersensitization assay will be formed and the role of Tor in chronic pain development will 
be explored.  Lastly, it is important that a more robust mechanical nociception assay 
exploring a wide array of behaviors is used for both Tor and Lk6 to analyze the responses 
produced by noxious mechanical stimuli.  
 
Conclusion 
It can be concluded that translation of proteins is essential to the proper development 
and function of the Drosophila nervous system. Well characterized signaling pathways that 
include the kinases Tor and Lk6 are imperative in the process of nociception and are able to 
regulate translation in unique ways. It was found that nociceptor-specific knockdown of Lk6 
played an important role in the development of thermal nociceptor sensitivity following UV 
induced tissue injury while playing no role in baseline nociceptor sensitivity. Lk6 likely 
controls the translation of mRNAs known to be involved in nociceptor plasticity or signal 
transduction. These mRNAs may include sodium and calcium channels as well as molecules 
such as GluRIIA, MMP9, chemokines, and cytokines that play a role in nociception. 
Nociceptor-specific knockdown of Tor showed phenotypes that eluded toward the 
involvement of the Tor signaling pathway in baseline nociceptor sensitivity and it 
hypothesized that Tor will play a role in the translation of mRNAs known to be involved in 
nociceptor plasticity in future experiments.  
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